Also trades as: MEDCL.PA (PAR) · $vol 2M
MDCLF OTC
MedinCell S.A.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +392.7%
1Y: +392.7%
3Y: +254.5%
$34.39
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$24M
-4.9% ▼
5Y CAGR: +24.3%
Gross Profit
$24M
-4.9% ▼
5Y CAGR: +29.2%
Operating Income
-$25M
-132.0% ▼
Net Income
-$31M
-70.3% ▼
EPS (Diluted)
$-0.87
-38.1% ▼
EBITDA
-$20M
-78.9% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $4M | $10M | $9M | $26M | $24M |
| YoY Growth | -50.0% | +143.1% | -7.9% | +178.8% | -4.9% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $4M | $10M | $9M | $26M | $24M |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| R&D Expenses | $24M | $28M | $21M | $24M | $27M |
| SG&A Expenses | $8M | $10M | $12M | $529K | $19M |
| Operating Expenses | $28M | $34M | $30M | $36M | $45M |
| Operating Income | -$24M | -$24M | -$21M | -$11M | -$25M |
| Operating Margin | -582.2% | -241.6% | -229.0% | -42.4% | -103.6% |
| Interest Expense | $2M | $4M | $5M | $5M | $7M |
| Income Before Tax | -$25M | -$32M | -$25M | -$18M | -$36M |
| Tax Expense | $0 | $0 | $88K | $160K | $69K |
| Net Income | -$25M | -$32M | -$25M | -$18M | -$31M |
| Net Margin | -606.5% | -321.9% | -273.3% | -72.2% | -129.4% |
| EPS (Diluted) | $-1.00 | $-1.27 | $-0.88 | $-0.63 | $-0.87 |
| EBITDA | -$21M | -$26M | -$19M | -$11M | -$20M |
| Shares Outstanding | 25M | 25M | 28M | 29M | 36M |